PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 19, 2026Cureus1 citationsOpen Access

Recurrent Shigella flexneri Gastroenteritis With Concurrent Rotavirus and SARS-CoV-2 Detection in a Preterm Infant: A Case Report

FFFilippos FilippatosNational and Kapodistrian University of AthensKKKonstantinos KakleasNational and Kapodistrian University of Athens

Key Points

  • This report aims to highlight a complex case of recurrent gastroenteritis caused by Shigella flexneri and concurrent viral infections in a preterm infant.
  • Stool culture performed to identify pathogens.
  • Gastrointestinal multiplex testing conducted to detect rotavirus and SARS-CoV-2.
  • Patient treated with rehydration, intravenous cefotaxime, and oral azithromycin.
  • Stool culture confirmed Shigella flexneri as the causative agent.
  • Subsequent episodes at 15 and 18 months revealed the same pathogen and treatment response to azithromycin.
  • Incidental detection of SARS-CoV-2 and rotavirus vaccine-strain shedding were noted, with uncertainty about their roles.

Abstract

We report a six-month-old male infant born late preterm at 35 weeks’ gestation who presented with fever, moderate dehydration, and bloody mucoid diarrhea. Stool culture yielded Shigella flexneri, while gastrointestinal multiplex testing also detected rotavirus and SARS-CoV-2. Only S. flexneri was culture-confirmed and clinically concordant with dysentery; rotavirus vaccine-strain shedding and incidental SARS-CoV-2 detection could not be excluded. The child improved with rehydration, intravenous cefotaxime, followed by oral azithromycin, and supportive care. Two later episodes at 15 and 18 months again yielded S. flexneri with the same antibiogram and responded to azithromycin. Because rotavirus strain typing, exact vaccination interval, and Shigella molecular typing were unavailable, neither viral causality nor relapse versus reinfection could be confirmed. The case emphasizes cautious interpretation of multiplex results, culture-guided therapy, household transmission risk, and infection-control measures in recurrent pediatric enteric infection.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Filippatos et al. (2026) studied this question.

synapsesocial.com/papers/6a0bfe08166b51b53d37958dhttps://doi.org/10.7759/cureus.109013
Ask AI
Helpful
Bookmark
Share
View Full Paper